Indian CRISPR diagnostics startup CrisprBits closed a US$3 million Pre‑Series A round led by Spectrum Impact, the family office of Rajendra Gogri, to expand diagnostics, gene‑editing tools and R&D. The financing will fund product development and scale-up of CRISPR‑based assays and platform capabilities. CrisprBits plans to deploy proceeds toward assay validation, regulatory filings and expanding laboratory capacity. The raise highlights sustained investor appetite in regionally focused CRISPR diagnostics that aim to reduce turnaround times and cost compared with centralized testing. For early-stage biotech in India, the round provides runway for translational activities and positions CrisprBits to pursue commercial pilots or partnerships with larger diagnostics firms.